DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Defense Health Agency Contracting Activity - DHACA · Department of Defense
At a glance
DoW Melanoma Research Program Focused Program Award – Rare Melanomas is an open federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). Applications are due October 14, 2026. Total estimated funding is $5.6M across about 2 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Posted
- May 21, 2026
- Close date
- Oct 14, 2026
- Archive date
- Nov 13, 2026
- Est. award date
- Sep 30, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $5,600,000
- Expected awards
- 2
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
Who can apply
- Unrestricted (any entity type)
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.
Distinctive Features:
· *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.
· This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.
- Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).
· After submitting the required pre-application, investigators must receive an invitation to submit a full application.
- Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.
· Clinical trials are allowed.
Assistance Listing
What is an ALN?Reported obligations under ALN 12.420
Historical data · not a predictionAgency contact (as published)
Jamie Shortall Grant Officer
help@eBRAP.org
301-619-2393
Quick answers
When is the deadline for “DoW Melanoma Research Program Focused Program Award – Rare Melanomas”?
According to the official notice, applications are due October 14, 2026. Confirm the deadline and submission time on Grants.gov before applying.
Who is eligible to apply for “DoW Melanoma Research Program Focused Program Award – Rare Melanomas”?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How much funding is available through “DoW Melanoma Research Program Focused Program Award – Rare Melanomas”?
Per the notice, total estimated program funding is $5,600,000 and the agency expects to make about 2 awards.
How do I apply for “DoW Melanoma Research Program Focused Program Award – Rare Melanomas”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526MRPFPARM), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
DoW Melanoma Research Program Melanoma Academy Scholar Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Survivorship Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Team Science Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Idea Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Traumatic Brain Injury and Psychological Health, Health Services Research Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 15, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 15, 2026
- Who can apply
- Unrestricted (any entity type)